Osaic Holdings
KYNB

Osaic Holdings’s Kyntra Bio KYNB Stock Holding History

Osaic Holdings’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37K Buy
182
+2
+1% +$14 ﹤0.01% 7394
2026
Q1 		$1.22K Buy
180
+78
+76% +$610 ﹤0.01% 7206
2025
Q4 		$895 Sell
102
-540
-84% -$5.28K ﹤0.01% 7308
2025
Q3 		$7.86K Hold
642
– – ﹤0.01% 6509
2025
Q2 		$3.4K Sell
642
-111
-15% -$810 ﹤0.01% 6740
2025
Q1 		$5.83K Buy
753
+545
+262% +$6.54K ﹤0.01% 6094
2024
Q4 		$2.75K Sell
208
-44
-17% -$409 ﹤0.01% 6480
2024
Q3 		$2.52K Sell
252
-12
-5% -$181 ﹤0.01% 6515
2024
Q2 		$5.26K Buy
264
+60
+29% +$1.85K ﹤0.01% 6149
2024
Q1 		$11.3K Buy
204
+144
+240% +$6.2K ﹤0.01% 5683
2023
Q4 		$1.32K Sell
60
-5
-8% -$75 ﹤0.01% 6663
2023
Q3 		$1.39K Sell
65
-230
-78% -$9.03K ﹤0.01% 6747
2023
Q2 		$20.4K Buy
295
+22
+8% +$9.1K ﹤0.01% 5549
2023
Q1 		$130K Sell
273
-74
-21% -$39.2K ﹤0.01% 4217
2022
Q4 		$138K Buy
347
+5
+1% +$1.92K ﹤0.01% 4165
2022
Q3 		$111K Sell
342
-4
-1% -$1.29K ﹤0.01% 4282
2022
Q2 		$96K Buy
346
+2
+0.6% +$511 ﹤0.01% 4456
2022
Q1 		$42K Sell
344
-12
-3% -$4.18K ﹤0.01% 5213
2021
Q4 		$130K Buy
356
+169
+90% +$52.6K ﹤0.01% 4341
2021
Q3 		$47K Sell
187
-142
-43% -$50.3K ﹤0.01% 5158
2021
Q2 		$219K Sell
329
-46
-12% -$26.5K ﹤0.01% 3794
2021
Q1 		$331K Buy
375
+11
+3% +$11.7K ﹤0.01% 3291
2020
Q4 		$337K Buy
364
+136
+60% +$143K ﹤0.01% 3013
2020
Q3 		$233K Buy
228
+33
+17% +$35.5K ﹤0.01% 3092
2020
Q2 		$198K Buy
195
+8
+4% +$7.43K ﹤0.01% 3147
2020
Q1 		$163K Buy
+187
New +$186K ﹤0.01% 3057

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Osaic Holdings's KYNB Position: Q2 2026 in Review

Osaic Holdings increased its Kyntra Bio (KYNB) stake by 1.1% in Q2 2026, buying an estimated $14 and bringing the position to 182 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #7394.

Osaic Holdings first reported a position in KYNB in Q1 2020 and has held it in 26 quarters since. The position peaked at $337K in Q4 2020. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • Osaic Holdings held 182 shares of Kyntra Bio worth $1.37K as of Q2 2026.
  • Osaic Holdings bought 2 Kyntra Bio shares in Q2 2026, an estimated $14.
  • Kyntra Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7394 holding.
  • Osaic Holdings first reported a position in Kyntra Bio in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Kyntra Bio position peaked at $337K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.